Latest news
Oculis Reports Q2 2026 Financial Results and Provides Company Update - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 20:05:00 GMTOculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 08:00:00 GMT